BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 24238348)

  • 21. Prediction of pathological stage in patients with clinical stage T1c prostate cancer: the new challenge.
    Veltri RW; Miller MC; Mangold LA; O'Dowd GJ; Epstein JI; Partin AW
    J Urol; 2002 Jul; 168(1):100-4. PubMed ID: 12050500
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The Incremental Role of Magnetic Resonance Imaging for Prostate Cancer Staging before Radical Prostatectomy.
    Morlacco A; Sharma V; Viers BR; Rangel LJ; Carlson RE; Froemming AT; Karnes RJ
    Eur Urol; 2017 May; 71(5):701-704. PubMed ID: 27576750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Counseling men with prostate cancer: a nomogram for predicting the presence of small, moderately differentiated, confined tumors.
    Kattan MW; Eastham JA; Wheeler TM; Maru N; Scardino PT; Erbersdobler A; Graefen M; Huland H; Koh H; Shariat S; Slawin KM; Ohori M
    J Urol; 2003 Nov; 170(5):1792-7. PubMed ID: 14532778
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Validation of 2001 Partin tables in Turkey: a multicenter study.
    Eskicorapci SY; Karabulut E; Türkeri L; Baltaci S; Cal C; Toktas G; Akpinar H; Ozer G; Sozen S; Tokuc R; Lekili M; Soylu A; Albayrak S; Sahin H; Alpar R; Ozen H
    Eur Urol; 2005 Feb; 47(2):185-9. PubMed ID: 15661412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MRI-Based Radiomics Signature for the Preoperative Prediction of Extracapsular Extension of Prostate Cancer.
    Ma S; Xie H; Wang H; Han C; Yang J; Lin Z; Li Y; He Q; Wang R; Cui Y; Zhang X; Wang X
    J Magn Reson Imaging; 2019 Dec; 50(6):1914-1925. PubMed ID: 31062459
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Seminal vesicle invasion on multi-parametric magnetic resonance imaging: Correlation with histopathology.
    Grivas N; Hinnen K; de Jong J; Heemsbergen W; Moonen L; Witteveen T; van der Poel H; Heijmink S
    Eur J Radiol; 2018 Jan; 98():107-112. PubMed ID: 29279147
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
    Steuber T; Karakiewicz PI; Augustin H; Erbersdobler A; Lange I; Haese A; Chun KH; Walz J; Graefen M; Huland H
    J Urol; 2005 Mar; 173(3):737-41. PubMed ID: 15711259
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
    Augustin H; Eggert T; Wenske S; Karakiewicz PI; Palisaar J; Daghofer F; Huland H; Graefen M
    J Urol; 2004 Jan; 171(1):177-81. PubMed ID: 14665871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prostate Magnetic Resonance Imaging Provides Limited Incremental Value Over the Memorial Sloan Kettering Cancer Center Preradical Prostatectomy Nomogram.
    Weaver JK; Kim EH; Vetter JM; Shetty A; Grubb RL; Strope SA; Andriole GL
    Urology; 2018 Mar; 113():119-128. PubMed ID: 29217354
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Application of a novel machine learning framework for predicting non-metastatic prostate cancer-specific mortality in men using the Surveillance, Epidemiology, and End Results (SEER) database.
    Lee C; Light A; Alaa A; Thurtle D; van der Schaar M; Gnanapragasam VJ
    Lancet Digit Health; 2021 Mar; 3(3):e158-e165. PubMed ID: 33549512
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic predisposition to early recurrence in clinically localized prostate cancer.
    Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
    BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor contact with prostate capsule on magnetic resonance imaging: A potential biomarker for staging and prognosis.
    Kongnyuy M; Sidana A; George AK; Muthigi A; Iyer A; Ho R; Chelluri R; Mertan F; Frye TP; Su D; Merino MJ; Choyke PL; Wood BJ; Pinto PA; Turkbey B
    Urol Oncol; 2017 Jan; 35(1):30.e1-30.e8. PubMed ID: 27567248
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage.
    Poulakis V; Witzsch U; De Vries R; Emmerlich V; Meves M; Altmannsberger HM; Becht E
    J Urol; 2004 Oct; 172(4 Pt 1):1306-10. PubMed ID: 15371829
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of patient-specific risk and percentile cohort risk of pathological stage outcome using continuous prostate-specific antigen measurement, clinical stage and biopsy Gleason score.
    Huang Y; Isharwal S; Haese A; Chun FK; Makarov DV; Feng Z; Han M; Humphreys E; Epstein JI; Partin AW; Veltri RW
    BJU Int; 2011 May; 107(10):1562-9. PubMed ID: 20875091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer.
    Blute ML; Bergstralh EJ; Partin AW; Walsh PC; Kattan MW; Scardino PT; Montie JE; Pearson JD; Slezak JM; Zincke H
    J Urol; 2000 Nov; 164(5):1591-5. PubMed ID: 11025711
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer.
    Wang L; Hricak H; Kattan MW; Schwartz LH; Eberhardt SC; Chen HN; Scardino PT
    AJR Am J Roentgenol; 2006 Mar; 186(3):743-8. PubMed ID: 16498101
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The identification and internal validation of a preoperative serum biomarker panel to determine extracapsular extension in patients with prostate cancer.
    Oon SF; Fanning DM; Fan Y; Boyce S; Murphy TB; Fitzpatrick JM; Watson RW
    Prostate; 2012 Oct; 72(14):1523-31. PubMed ID: 22415934
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Accuracy of Multiparametric Magnetic Resonance Imaging for Extracapsular Extension of Prostate Cancer in Community Practice.
    Davis R; Salmasi A; Koprowski C; Kim S; Kwon YS; Faiena I; Patel N; Elsamra SE; Kim IY
    Clin Genitourin Cancer; 2016 Dec; 14(6):e617-e622. PubMed ID: 27188968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Artificial neural network for predicting pathological stage of clinically localized prostate cancer in a Taiwanese population.
    Tsao CW; Liu CY; Cha TL; Wu ST; Sun GH; Yu DS; Chen HI; Chang SY; Chen SC; Hsu CY
    J Chin Med Assoc; 2014 Oct; 77(10):513-8. PubMed ID: 25175002
    [TBL] [Abstract][Full Text] [Related]  

  • 40. External validation of the updated partin tables in a cohort of French and Italian men.
    Bhojani N; Salomon L; Capitanio U; Suardi N; Shariat SF; Jeldres C; Zini L; Pharand D; Péloquin F; Arjane P; Abbou CC; De La Taille A; Montorsi F; Karakiewicz PI
    Int J Radiat Oncol Biol Phys; 2009 Feb; 73(2):347-52. PubMed ID: 19004573
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.